{
  "id": 20733884,
  "title": "Palliser Capital pushes for break-up of UK defence group Chemring",
  "url": "https://urgent.news/2026/11/19/palliser-capital-pushes-for-break-up-of-uk-defence-group-chemring",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-19T10:19:00.000Z",
  "source": {
    "name": "Hedgeweek",
    "slug": "hedgeweek",
    "url": "https://hedgeweek.com/news/palliser-capital-pushes-for-break-up-of-uk-defence-group-chemring"
  },
  "original_language": "en",
  "account": "UK defence group Chemring is facing pressure from activist investors to break up the company, according to a Financial Times report. Palliser Capital, led by former Elliott Management executive James Smith, holds about 3% of Chemring's shares and is urging the board to consider a strategic review, including potential sale of its electronic warfare and defence engineering subsidiary Roke. Palliser estimates Roke could be worth between £600m and £730m as an independent business. By separating the company, Palliser argues Chemring could capitalize on rising European military spending and unlock significant shareholder value, particularly for its energetics division, which produces military explosives, missile components, and defensive countermeasures. Despite increased defence spending following Russia's invasion of Ukraine, Chemring has delivered the weakest shareholder returns among its peers during the current rearmament cycle, according to Palliser. The company's market capitalization is around £1.4bn, and its shares have remained largely unchanged over the past year. Palliser claims Chemring has benefited from increased demand, with a record order book of £1.4bn for the financial year ending October, but delays in contract awards within its UK sensors business led to an 8% decline in operating profit to £24.5m in the six months to April. The activist campaign coincides with a leadership transition at Chemring, with CEO Michael Ord set to retire in January and his successor, Tom Newman, joining the company in October. Private equity investor Albion River holds the largest stake, with Palliser requesting a meeting with Chemring chair Tony Wood and previously engaging with the company's management.",
  "summary": "Palliser Capital is calling for a break-up of UK defence group Chemring, arguing that the company has failed to capitalise on rising European military spending and could unlock significant shareholder value by separating its businesses, according to a report by the Financial Times. The London-based investment firm, led by former Elliott Management executive James Smith, has accumulated a stake of…",
  "key_points": [
    "Palliser Capital, led by James Smith, owns 3% of Chemring shares.",
    "Palliser wants Chemring to review and potentially sell Roke subsidiary.",
    "Roke could be worth £600m to £730m as an independent business."
  ],
  "editors_take": "This activist push signals a shift toward dismantling integrated defense groups to unlock value from specialized subsidiaries as European military spending climbs despite stagnant shareholder returns.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}